lazarus shares a report from Phys.org: Two Arizona State University astrophysicists, Steven Desch and Alan Jackson of the School of Earth and Space Exploration, set out to explain the odd features of 'Oumuamua and have determined that it is likely a piece of a Pluto-like planet from another solar system. Desch and Jackson hypothesized that the object was made of different ices and calculated how quickly these ices would sublimate (passing from a solid to a gas) as 'Oumuamua passed by the sun. From there, they calculated the rocket effect, the object's mass and shape, and the reflectivity of the ices.

The scientists found one ice in particular -- solid nitrogen -- that provided an exact match to all the object's features simultaneously. And since solid nitrogen ice can be seen on the surface of Pluto, it is possible that a comet-like object could be made of the same material. "We knew we had hit on the right idea when we completed the calculation for what albedo (how reflective the body is) would make the motion of 'Oumuamua match the observations," said Jackson, who is a research scientist and an Exploration Fellow at ASU. "That value came out as being the same as we observe on the surface of Pluto or Triton, bodies covered in nitrogen ice."

They then calculated the rate at which chunks of solid nitrogen ice would have been knocked off the surfaces of Pluto and similar bodies early in our solar system's history. And they calculated the probability that chunks of solid nitrogen ice from other solar systems would reach ours. "It was likely knocked off the surface by an impact about half a billion years ago and thrown out of its parent system," Jackson said. "Being made of frozen nitrogen also explains the unusual shape of 'Oumuamua. As the outer layers of nitrogen ice evaporated, the shape of the body would have become progressively more flattened, just like a bar of soap does as the outer layers get rubbed off through use."

An anonymous reader quotes a report from The New York Times: The mouse embryos looked perfectly normal. All their organs were developing as expected, along with their limbs and circulatory and nervous systems. Their tiny hearts were beating at a normal 170 beats per minute. But these embryos were not growing in a mother mouse. They were developed inside an artificial uterus, the first time such a feat has been accomplished, scientists reported on Wednesday.

The experiments, at the Weizmann Institute of Science in Israel, were meant to help scientists understand how mammals develop and how gene mutations, nutrients and environmental conditions may affect the fetus. But the work may one day raise profound questions about whether other animals, even humans, should or could be cultured outside a living womb. In a study published in the journal Nature, Dr. Jacob Hanna described removing embryos from the uteruses of mice at five days of gestation and growing them for six more days in artificial wombs. At that point, the embryos were about halfway through their development; full gestation is about 20 days. A human at this stage of development would be called a fetus. To date, Dr. Hanna and his colleagues have grown more than 1,000 embryos in this way.

But the research has already progressed beyond what the investigators described in the paper. In an interview, Dr. Hanna said he and his colleagues had taken fertilized eggs from the oviducts of female mice just after fertilization -- at Day 0 of development -- and had grown them in the artificial uterus for 11 days. [...] The artificial womb may allow researchers to learn more about why pregnancies end in miscarriages or why fertilized eggs fail to implant. It opens a new window onto how gene mutations or deletions affect fetal development. Researchers may be able to watch individual cells migrate to their ultimate destinations.

NASA is counting down to what should be the final major test of the massive rocket it is building to put the first woman and the next man on the moon. From a report: More than 700,000 gallons of supercold propellant will fill up the tanks of the 212-foot tall core stage so that it can fire its four engines without actually blasting off. The goal is to simulate what will happen during its first launch, a mission to send a capsule with no crew around the moon and back. That lunar mission is currently targeted for November, says NASA's acting administrator Steve Jurczyk, who notes that this rocket "is going to be the most powerful rocket ever developed." The window for the rocket test opens on Thursday, March 18, at 3 pm EDT, and the core stage of the rocket is set up at NASA's Stennis Space Center in Mississippi. In a firing test earlier this year, one of the rocket's engines had a failure that forced an early shutdown after only 67 seconds.

"We can understand exactly what happened in the first test and what cut it short," says Jurczyk, who explains that one test parameter had been set too narrowly and that's now been fixed. "Start up on the first test went really well, and so we're reasonably confident we're going to have a good test this week." The test should last around eight minutes, to simulate the entire flight profile of this rocket stage, he explains, but the minimum of what they'd like to see is around 4 minutes. If all goes well, the rocket will move on to Kennedy Space Center in Florida, where the rest of the launch hardware is already waiting. Under the Trump administration, the agency had been aiming to get boots on the lunar surface by 2024, which would have been in a second term if the former president had been re-elected. That deadline was a goal that most in the space community felt was unrealistic. These days, NASA admits that there's no way to get people to the moon that quickly, given the recent appropriations given by Congress.

A whole list of countries -- including Germany, France, Italy, Spain, Sweden and Latvia -- have suspended dosing of the AstraZeneca/Oxford vaccine over reports of dangerous blood clots in some recipients. The company and international regulators say there is no evidence the shot is to blame, but that isn't stopping countries from taking action out of an abundance of caution. Derek Lowe, a medical chemist working in the pharmaceutical industry, explains what's going on with this vaccine: I think that there are several distinct levels to this problem. The first, obviously, is medical. The big question is, are the reports of vascular problems greater than one would expect in the vaccinated population as a whole? It's not clear to me what the answer is, and it may very well be "No, they aren't." That CNBC link above quotes Michael Head at Southampton as saying that the data so far look like the problems show up at at least the same levels, and may even be lower in the vaccinated group. AstraZeneca has said that they're aware of 15 events of deep vein thrombosis and 22 events pulmonary embolisms, but that's in 17 million people who have had at least one shot -- and they say that is indeed "much lower than would be expected to occur naturally in a general population of this size." It also appears to be similar to what's been seen with the other coronavirus vaccines, which rather than meaning "they're all bad" looks like they're all showing the same baseline signal of such events across a broad population, without adding to it.

In that case, this could be an example of what I warned about back in December (and many others have warned about as well), the post hoc ergo propter hoc "false side effects" problem. I've been looking this morning, and so far have not found anyone clearly stating that the problems seen are running higher in the vaccinated patients [...]. I realize that there's a possibility (not a likely one, though) that some particular batch of vaccine is more problematic, but I haven't seen any solid evidence of that, either.

The second half of the medical problem is naturally what happens when you suspend dosing of what is, in many cases in the EU, the only vaccine available. We've been seeing cases falling here in the US ever since a peak on the first week of January -- many of us were worried about what might have been a rise in February but which now just seems to have been a plateau, with cases continuing to drop since then. But many European countries are definitely seeing another wave of infections, and the EU case numbers as a whole are going in the opposite direction to the US ones. There are surely a lot of reasons for this, with new viral variants being one, slow vaccine rollouts being another, and now complete vaccination halts set to add even more. Put as bluntly as possible, even if the AZ/Oxford vaccine has these side effects (which again, I don't see any evidence for yet), you are still very likely to kill more people by not giving it. Lowe goes on to question what good the EMA and World Health Organization's recommendations and regulatory approvals are when one European country after another shuts down its use.

He also brings up the third problem, which is public confidence. "The AZ/Oxford vaccine has been in trouble there since the day the first data came out," writes Lowe. "The efficacy numbers looked lower than the other vaccines that had reported by then, and as mentioned, the presentation of the data was really poorly handled and continued to be so for weeks. Now with these dosing suspensions, I have to wonder if this vaccine is ever going to lose the dark cloud it's currently sitting under..."

Oceans' worth of water may remain buried in the crust of Mars, and not lost to space as previously long thought, a new study finds. Space.com reports: Data from NASA's MAVEN (Mars Atmosphere and Volatile EvolutioN) mission and the European Space Agency's Mars Express orbiter revealed that at the rate water disappears from the Red Planet's atmosphere, Mars would have lost a global ocean of water only about 10 to 82 feet (3 to 25 m) deep over the course of 4.5 billion years. Now scientists find that much of the water Mars once had may remain hidden in the crust of the Red Planet, locked away in the crystal structures of rocks beneath the Martian surface. They detailed their findings online March 16 in the journal Science and at the Lunar Planetary Science Conference.

In the new study, the scientists found chemical reactions may have led between 30% to 99% of the water that Mars initially had to get locked into minerals and buried in the planet's crust. Any remaining water was then lost to space, explaining the hydrogen-to-deuterium ratios seen on Mars. All in all, the researchers suggested Mars lost 40% to 95% of its water during its Noachian period about 4.1 billion to 3.7 billion years ago. Their model suggested the amount of water on the Red Planet reached its current levels by about 3 billion years ago.

New submitter byennie writes: A new airless bicycle tire called "METL" was introduced today by The SMART Tire Company. The tire is made from shape memory alloys (SMAs) and was originally designed for Mars rover missions (it's headed to Mars in 2026 as part of the Fetch rover). The structural tire claims to be flat-free and high performance, leaning on the unique properties of SMAs developed at NASA for future heavy vehicles in space. According to the company, "the shape memory alloy tire is made from advanced, lightweight materials known as NiTinol+, creating a tire that is elastic like rubber yet strong like titanium, exhibiting perfect shape memory without ever going flat."

An anonymous reader quotes a report from NPR: In 2016, a family in Illinois thought that a meteorite had hit their backyard. They called up the geology department at nearby Wheaton College to say that whatever struck their property had started a small fire and had left a weird rock embedded in the scorched dirt. "Meteorites, contrary to popular belief, are cold when they hit the ground," says Benjamin Hess, who was an undergraduate at the college but is now a graduate student at Yale University. "My professor readily figured out that that was probably a lightning strike."

When lightning strikes sand, soil or stone, it immediately melts the materials into a glassy clump known as a fulgurite, or lightning rock. When geologists excavated the fulgurite in Illinois, they found something unexpected inside -- an important ingredient for life that had long been thought to be delivered to early Earth by meteorites. A report on the find, in the journal Nature Communications, suggests that this could have been a way for lightning to have played a key role in the emergence of life.

When the researchers dug out the fulgurite in Illinois, they first saw glassy bits on its surface. Below that was a thick, tree-root-like structure extending down about a foot and a half. Hess and two colleagues at the University of Leeds analyzed the minerals inside and found one called schreibersite. This reactive mineral contains phosphorus, an essential element for life. Phosphorus "really plays a key role in a lot of the basic cell structures," says Hess. For example, it makes up the backbone of DNA. Phosphorus was abundant in early Earth, but geologists know that it was mostly inaccessible because it was trapped inside nonreactive minerals that don't dissolve easily in water. One explanation for where the phosphorus came from is meteorites, which can contain reactive minerals like schreibersite. But, according to the researchers, lightning offers an alternative source as it doesn't destroy an entire 100-kilometer area when it strikes and there could have been 1 billion to 5 billion lightning flashes every year when life firm emerged, about 3.5 billion years ago.

schwit1 shares a report from Phys.Org: A new study led by scientists at the University of Miami (UM) Rosenstiel School of Marine and Atmospheric Science demonstrates that under realistic environmental conditions oil drifting in the ocean after the DWH oil spill photooxidized into persistent compounds within hours to days, instead over long periods of time as was thought during the 2010 Deepwater Horizon oil spill. This is the first model results to support the new paradigm of photooxidation that emerged from laboratory research.

After an oil spill, oil droplets on the ocean surface can be transformed by a weathering process known as photooxidation, which results in the degradation of crude oil from exposure to light and oxygen into new by-products over time. Tar, a by-product of this weathering process, can remain in coastal areas for decades after a spill. Despite the significant consequences of this weathering pathway, photooxidation was not taken into account in oil spill models or the oil budget calculations during the Deepwater Horizon spill. The UM Rosenstiel School research team developed the first oil-spill model algorithm that tracks the dose of solar radiation oil droplets receive as they rise from the deep sea and are transported at the ocean surface. The authors found that the weathering of oil droplets by solar light occurred within hours to days, and that roughly 75 percent of the photooxidation during the Deepwater Horizon oil spill occurred on the same areas where chemical dispersants were sprayed from aircraft. Photooxidized oil is known to reduce the effectiveness of aerial dispersants. The study has been published in the journal Frontiers in Marine Science.

Germany on Monday halted use of the AstraZeneca coronavirus vaccine, the Health Ministry announced in a statement, with Italy, France and Spain following suit later in the day. Several other EU countries have stopped use of the vaccine because of the possibility of blood clots. From a report: The Health Ministry announced that use of the vaccine was "suspended as a precaution" on the basis of advice from the national health regulator, the Paul Ehrlich Institute (PEI). According to the Health Ministry, the European Medicines Agency (EMA) will decide "whether and how the new information will affect the authorization of the vaccine" pending an investigation. "After new reports of thrombroses of the cerebral veins in connection with the vaccination in Germany and Europe, the PEI considers further investigations to be necessary," the Health Ministry announced. German Health Minister Jens Spahn said "the decision is a professional, not political one," following advice from the PEI. Spahn said the risk of blood clots from the AstraZeneca jab is low, but could not be ruled out. "The most important thing for confidence is transparency," Spahn said during a briefing.

The Washington Post reports: Facebook is conducting a vast behind-the-scenes study of doubts expressed by U.S. users about vaccines, a major project that attempts to probe and teach software to identify the medical attitudes of millions of Americans, according to documents obtained by The Washington Post. The research is a large-scale attempt to understand the spread of ideas that contribute to vaccine hesitancy, or the act of delaying or refusing a vaccination despite its availability, on social media — a primary source of health information for millions of people...

Its early findings suggest that a large amount of content that does not break the rules may be causing harm in certain communities, where it has an echo chamber effect... Just 10 out of the 638 population segments contained 50 percent of all vaccine hesitancy content on the platform. And in the population segment with the most vaccine hesitancy, just 111 users contributed half of all vaccine hesitant content... The research effort also discovered early evidence of significant overlap between communities that are skeptical of vaccines and those affiliated with QAnon, a sprawling set of baseless claims that has radicalized its followers and been associated with violent crimes, according to the documents...

Facebook, which owns WhatsApp messenger and Instagram, collects reams of data on its more than 3.3 billion users worldwide and has a broad reach onto those users' devices. Public health experts say that puts the company in a unique position to examine attitudes toward vaccines, testing and other behaviors and push information to people.

But the company has a steep hill to climb when it comes to proving that its research efforts serve the public because of its history of misusing people's data.
Facebook is removing content which violates its policies. Yet the documents obtained by the Post say "While research is very early, we're concerned that harm from non-violating content may be substantial."

CBS News reports: Scientists are pulling inspiration from Noah's Ark in a new lunar proposal that they call a "global insurance policy." They hope to send an ark to the moon, filled with 335 million sperm and egg samples, in case a catastrophe happens on Earth. Instead of two of every animal, the solar-powered moon ark would cryogenically store frozen seed, spore, sperm and egg samples from some 6.7 million Earth species. University of Arizona researcher Jekan Thanga and a group of his students proposed the concept in a paper presented during the IEEE Aerospace Conference this week...

Establishing the ark would involve sending the 6.7 million samples to the moon in multiple payloads, then storing them in a vault beneath the surface, where they would be safe. The idea is to store the ark within a network of lava tubes — about 200 of which were discovered beneath the moon's surface in 2013... These tubes have remained untouched for three to four billion years, and scientists suggest they could provide much-needed protection from solar radiation, meteors or temperature changes on the surface. While the moon is not hospitable to humans, its harsh features "make it a great place to store samples that need to stay very cold and undisturbed for hundreds of years at a time," they said.

Based on some "quick, back-of-the-envelope calculations," Thanga said that transporting about 50 samples from each of 6.7 million species — totaling 335 million samples — would take about 250 rocket launches. That's over six times more than it took to build the International Space Station, which required 40 rocket launches. "It's not crazy big," Thanga said. "We were a little bit surprised about that."

The team's proposal for the ark includes solar panels on the moon's surface for electricity, elevator shafts down into the facility and Petri dishes housed in cryogenic preservation modules.
"What amazes me about projects like this is that they make me feel like we are getting closer to becoming a space civilization," said the University of Arizona doctoral student leading the thermal analysis for the project, "and to a not-very-distant future where humankind will have bases on the moon and Mars."

The Verge reports: A SpaceX Falcon 9 rocket launched the latest batch of 60 Starlink satellites into orbit Sunday, and returned to Earth successfully, landing on its Of Course I Still Love You drone ship in the Atlantic Ocean, the company announced. Sunday's mission marked a record ninth flight and landing for this Falcon 9 booster, SpaceX said...

Sunday's launch from NASA's Kennedy Space Center was the second in the past few days for SpaceX, which sent another of its Falcon 9 rockets skyward from Cape Canaveral Space Force Station on Thursday. That launch also brought 60 satellites into orbit.
Sharing a video about the mission, CNET calls it "a new standard for rocket recycling." The first stage that boosted the satellites is a veteran of five previous Starlink missions, Crew Dragon's first demonstration flight, a SiriusXM satellite launch and a Canadian Space Agency satellite mission. The fairing, or nose cone, also previously flew on the Transporter-1 ride-share mission.

The CBC Radio show Quirks and Quarks shares an interesting theory: If you find yourself pondering the marvel of aerodynamics when you fly on a plane, or if you concentrate on the structure of music as it plays, rather than simply listening, you may score high on measures of "systemization," according to University of Cambridge neuroscientist Simon Baron-Cohen.

And if so this may reflect abilities that he thinks may have first evolved in humans between 70,000 and 100,000 years ago, when our human ancestors took a cognitive leap forward. This new capacity enabled them to analyze and understand patterns in the world that would, among other things, facilitate the invention of complex tools from bows to musical instruments. In Baron-Cohen's new book, he argues that humans became "the scientific and technological masters of our planet" because of our brain's "systemizing mechanism."

Also, some individuals — particularly those with Autism Spectrum Disorder, are the "hyper-systemizers" of our world. He suggests this should cause us to re-evaluate the capacities and strengths of people with autism... "[F]or the longest time, autism has been really just characterized as a disability, which it is, but with a focus on all the things that autistic people find difficult, what they struggle with. But we know that autism is more than just a disability, that autistic people think differently. Sometimes they have strengths...

"The fact that we can now see a link between those strengths in autism and human invention may change the way we look at autistic people. We might want to see them for who they are, people who think differently and have contributed to human progress."

Eli Lilly and Company's experimental intravenous drug donanemab "could slow the cognitive decline of patients with Alzheimer's disease," reports CNN, citing early clinical trial results, published today in The New England Journal of Medicine: The study included 257 patients with early symptomatic Alzheimer's disease; 131 received donanemab, while 126 received a placebo. The researchers found donanemab slowed the decline of cognition and daily function in Alzheimer's patients by 32% after 76 weeks, compared to those who received a placebo. Taken over 18 months, that 32% slowing of decline could be noticeably impactful for Alzheimer's patients, noted Maria Carrillo, chief science officer at the Alzheimer's Association, who was not involved in the study. "Out of 18 months, in comparison to the people that did not get the drug, these folks were declining six months slower," Carrillo said. "That's six more months of better cognition, better memories, better enjoyable times with your family...."

"This has a lot of potential," Carrillo added. "It could be a first step towards slowing more significantly, or stopping, cognitive decline in these earlier stages, which would really be transformational for our field..."

The researchers also looked at the drug's impact on the buildup of amyloid beta plaque and tau proteins, which are considered hallmarks of Alzheimer's disease. At 52 weeks, almost 60% of participants had reached amyloid-negative status, meaning their levels were at those of otherwise healthy people. At 76 weeks, amyloid plaque levels — measured in centiloids — decreased by 85 centiloids more than in those who received the placebo, the researchers reported...

"We are extremely pleased about these positive findings for donanemab as a potential therapy for people living with Alzheimer's disease, the only leading cause of death without a treatment that slows disease progression," Dr. Mark Mintun, Eli Lilly's vice president of pain and neurodegeneration, said in a January statement announcing the trial results...

Alzheimer's disease is the most common form of dementia, and currently affects 6.2 million Americans age 65 and older, according to the Alzheimer's Association.

"Two companies are selling diamonds made in a laboratory from CO2 that once circled the Earth," reports Scientific American: The sales pitch can be stunning. As Ryan Shearman, the founder and CEO of a New York-based company called Aether, recently explained to a reporter for Vogue magazine: Each carat of a diamond removes 20 tons of CO2. That, he said, is more invisible gas than the average person produces in a year.

With the purchase of a 2-carat diamond, Shearman pointed out, "you're essentially offsetting 2 and a half years of your life."

It can take Mother Nature as long as a billion years to make diamonds, which are formed in rocks. But as Shearman explained in an interview with E&E News, he has developed a patent-pending process that can make a batch of diamonds in a laboratory in four weeks. Unlike other laboratory-made diamonds, his process starts with CO2 removed from the air. The gas undergoes a chemical reaction where it is subjected to high pressure and extremely high temperatures. All of this is created using solar, wind or hydraulic power. Or, as Shearman sometimes puts it, "we're committed to the unprecedented modern alchemy of turning air pollution into precious stones." Aether has been selling its diamonds since the beginning of the year at prices ranging from $7,000 for a ring to around $40,000 for earrings with sparkling stone arrangements.

Aether has a competitor, a British company called Skydiamond...

"Tens of millions of doses of the coronavirus vaccine made by the British-Swedish company AstraZeneca are sitting idly in American manufacturing facilities," reports the New York Times, "awaiting results from its U.S. clinical trial while countries that have authorized its use beg for access."

schwit1 shares their report: The fate of those doses of AstraZeneca's vaccine is the subject of an intense debate among White House and federal health officials, with some arguing the administration should let them go abroad where they are desperately needed while others are not ready to relinquish them, according to senior administration officials...

About 30 million doses are currently bottled at AstraZeneca's facility in West Chester, Ohio, which handles "fill-finish," the final phase of the manufacturing process during which the vaccine is placed in vials, one official with knowledge of the stockpile said. Emergent BioSolutions, a company in Maryland that AstraZeneca has contracted to manufacture its vaccine in the United States, has also produced enough vaccine in Baltimore for tens of millions more doses once it is filled into vials and packaged, the official said. But although AstraZeneca's vaccine is already authorized in more than 70 countries, according to a company spokesman, its U.S. clinical trial has not yet reported results, and the company has not applied to the Food and Drug Administration for emergency use authorization.

AstraZeneca has asked the Biden administration to let it loan American doses to the European Union, where it has fallen short of its original supply commitments and where the vaccination campaign has stumbled badly. The administration, for now, has denied the request, one official said...

Johnson & Johnson, which has authorization for its vaccine in the United States but fell behind on its production targets in both the United States and Europe, recently asked the United States to loan 10 million doses to the European Union, but the Biden administration also denied that request, according to American and European officials... The administration has focused on Johnson & Johnson's one-shot vaccine, brokering a deal to have the pharmaceutical giant Merck manufacture and bottle the shot and announcing plans to secure 100 million additional doses... Privately, two senior administration officials said that by helping Johnson & Johnson scale up with the Merck deal, the White House is laying the groundwork for the company to eventually make its vaccine available overseas.

The Washington Post reports: Tesla's Bay Area production plant recorded hundreds of covid-19 cases following CEO Elon Musk's defiant reopening of the plant in May, according to county-level data obtained by a legal transparency website.

The document, obtained by the website PlainSite following a court ruling this year, showed Tesla received around 10 reports of covid-19 in May when the plant reopened, and saw a steady rise in cases all the way up to 125 in December, as the disease caused by the novel coronavirus peaked around the country. The revelation follows The Washington Post's reporting in June that there had been multiple covid-19 cases reported at Tesla's facilities in Fremont, Calif., after Musk decided to reopen despite a countywide stay-at-home order, daring officials to arrest him. The data, covering the months between May and December, showed there were around 450 total reported cases. Roughly 10,000 people work at the plant...

Despite around 10 cases in May, according to the data, the health department told The Post in early June that there were no known cases of workplace infections affecting county residents. Tesla and the Alameda County Public Health Department and representatives did not respond to a request for comment...

Tesla also came under fire for its treatment of workers. It had promised they could remain home if they felt uncomfortable returning to the line. The Post reported in late June and July that workers concerned about covid exposure received termination notices after they did not return to work. The data released by Alameda County shows there were 19 reported cases in June and 58 reported cases at the plant in July.

Adrian Cho writes via Science Magazine: From 1966 to 1974, France blew up 41 nuclear weapons in above-ground tests in French Polynesia, the collection of 118 islands and atolls that is part of France. The French government has long contended that the testing was done safely. But a new analysis of hundreds of documents declassified in 2013 suggests the tests exposed 90% of the 125,000 people living in French Polynesia to radioactive fallout -- roughly 10 times as many people as the French government has estimated.

The findings come from a 2-year collaboration, dubbed the Moruroa Files, between Disclose, a French nonprofit that supports investigative journalism; Interprt, a collective of researchers, architects, and spatial designers affiliated with the Norwegian University of Science and Technology who focus on environmental issues; and the Science & Global Security program at Princeton. The findings were presented on 9 March on the project's website, in a book, and in a technical paper posted to the arXiv preprint server. Most French Polynesians were exposed to a relatively small amount of radiation, and the central issue is who is eligible for compensation under French law.

Scientists have used 3D computer modeling to figure out how the world's oldest "computer" worked. BBC reports: The Antikythera Mechanism has baffled experts since it was found on a Roman-era shipwreck in Greece in 1901. The hand-powered Ancient Greek device is thought to have been used to predict eclipses and other astronomical events. But only a third of the device survived, leaving researchers pondering how it worked and what it looked like. Scientists from University College London (UCL) believe they have finally cracked the puzzle using 3D computer modeling. They have recreated the entire front panel, and now hope to build a full-scale replica of the Antikythera using modern materials.

On Friday, a paper published in Scientific Reports revealed a new display of the gearing system that showed its fine details and complex parts. The mechanism has been described as an astronomical calculator as well as the world's first analogue computer. It is made of bronze and includes dozens of gears. The back cover features a description of the cosmos display, which shows the motion of the five planets that were known at the time the device was built. But only 82 fragments -- amounting to around a third of the device -- survived, This meant scientists have had to piece together the full picture using X-Ray data and an Ancient Greek mathematical method.

Japan's Fugaku supercomputer, the world's fastest in terms of computing speed, went into full operation this week, earlier than initially scheduled, in the hope that it can be used for research related to the novel coronavirus. From a report: The supercomputer, named after an alternative word for Mount Fuji, became partially operational in April last year to visualize how droplets that could carry the virus spread from the mouth and to help explore possible treatments for COVID-19. "I hope Fugaku will be cherished by the people as it can do what its predecessor K couldn't, including artificial intelligence (applications) and big data analytics," said Hiroshi Matsumoto, president of the Riken research institute that developed the machine, in a ceremony held at the Riken Center for Computational Science in Kobe, where it is installed. Fugaku, which can perform over 442 quadrillion computations per second, was originally scheduled to start operating fully in the fiscal year from April. It will eventually be used in fields such as climate and artificial intelligence applications, and will be used in more than 100 projects, according to state-sponsored Riken.